A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

GSK Investigational Site, Brussels

GSK Investigational Site, Budapest

GSK Investigational Site, Brussels

GSK Investigational Site, Edegem

GSK Investigational Site, Miskolc

GSK Investigational Site, Liège

GSK Investigational Site, Debrecen

GSK Investigational Site, Nyíregyháza

GSK Investigational Site, Namur

GSK Investigational Site, Szeged

GSK Investigational Site, Pécs

GSK Investigational Site, Barcelona

GSK Investigational Site, L'Hospitalet de Llobregat

GSK Investigational Site, Aalst

GSK Investigational Site, Cáceres

GSK Investigational Site, Lake Success

GSK Investigational Site, Clifton Park

GSK Investigational Site, Nea Kifissia

GSK Investigational Site, Marousi

GSK Investigational Site, Genoa

GSK Investigational Site, Neo Faliro

GSK Investigational Site, Philadelphia

GSK Investigational Site, Milan

GSK Investigational Site, Dijon

GSK Investigational Site, Low Moor

GSK Investigational Site, Lleida

GSK Investigational Site, Cremona

GSK Investigational Site, Lugo

GSK Investigational Site, Madrid

GSK Investigational Site, Pamplona

GSK Investigational Site, Bordeaux

GSK Investigational Site, Miami

GSK Investigational Site, Fort Myers

GSK Investigational Site, Montpellier

GSK Investigational Site, Vigo

GSK Investigational Site, Legnago (VR)

GSK Investigational Site, Nashville

GSK Investigational Site, Nashville

GSK Investigational Site, Parma

GSK Investigational Site, Cleveland

GSK Investigational Site, Nantes

GSK Investigational Site, Kfar Saba

GSK Investigational Site, Valencia

GSK Investigational Site, Valencia

GSK Investigational Site, Meldola (FC)

GSK Investigational Site, Rimini

GSK Investigational Site, Tel Litwinsky

GSK Investigational Site, Green Bay

GSK Investigational Site, Thessaloniki

GSK Investigational Site, Holon

GSK Investigational Site, Lille

GSK Investigational Site, Prato

GSK Investigational Site, Ancona

GSK Investigational Site, Omaha

GSK Investigational Site, Lyon

GSK Investigational Site, Heraklion,Crete

GSK Investigational Site, Lecce

GSK Investigational Site, Dallas

GSK Investigational Site, Paris

GSK Investigational Site, Rehovot

GSK Investigational Site, Fort Worth

GSK Investigational Site, Webster

GSK Investigational Site, San Antonio

GSK Investigational Site, Weslaco

GSK Investigational Site, Tucson

GSK Investigational Site, Henderson

GSK Investigational Site, Los Angeles

GSK Investigational Site, Los Angeles

GSK Investigational Site, Saint-Cloud

GSK Investigational Site, Portland

GSK Investigational Site, Eugene

GSK Investigational Site, Seattle

GSK Investigational Site, Everett

GSK Investigational Site, Haifa

GSK Investigational Site, Tel Aviv

GSK Investigational Site, Boston

GSK Investigational Site, Calgary

GSK Investigational Site, Kelowna

GSK Investigational Site, Toronto

GSK Investigational Site, Montreal

GSK Investigational Site, Reykjavik

GSK Investigational Site, Viterbo

GSK Investigational Site, Leiden, RC

GSK Investigational Site, Limburg

GSK Investigational Site, Zwolle

GSK Investigational Site, Lodz

GSK Investigational Site, Racibórz

GSK Investigational Site, Coimbra

GSK Investigational Site, Lisbon

GSK Investigational Site, Porto

GSK Investigational Site, Burgos

GSK Investigational Site, Southampton

GSK Investigational Site, Northwood

GSK Investigational Site, Headington, Oxford

GSK Investigational Site, Sutton

GSK Investigational Site, Bebington, Wirral

GSK Investigational Site, Belfast

GSK Investigational Site, Edinburgh

GSK Investigational Site, Glasgow

GSK Investigational Site, London

GSK Investigational Site, London

GSK Investigational Site, London

GSK Investigational Site, Nottingham

GSK Investigational Site, Whitchurch, Cardiff